Summit Global Investments’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.29M Sell
4,421
-5,190
-54% -$1.71M 0.08% 139
2025
Q4
$3.37M Sell
9,611
-4,644
-33% -$1.57M 0.2% 58
2025
Q3
$4.61M Sell
14,255
-926
-6% -$288K 0.27% 59
2025
Q2
$5.91M Sell
15,181
-5,383
-26% -$2.17M 0.35% 53
2025
Q1
$8.95M Sell
20,564
-4,408
-18% -$1.77M 0.65% 26
2024
Q4
$9.21M Sell
24,972
-2,544
-9% -$1.06M 0.58% 41
2024
Q3
$14.3M Buy
27,516
+505
+2% +$270K 0.91% 20
2024
Q2
$14.6M Sell
27,011
-5,737
-18% -$3.03M 0.99% 20
2024
Q1
$17M Sell
32,748
-8,476
-21% -$4.22M 1.26% 12
2023
Q4
$19.4M Sell
41,224
-3,919
-9% -$1.81M 1.27% 14
2023
Q3
$19.7M Buy
45,143
+29,422
+187% +$13.3M 1.31% 11
2023
Q2
$6.99M Buy
15,721
+12,765
+432% +$5.89M 0.46% 57
2023
Q1
$1.36M Buy
+2,956
New +$1.41M 0.11% 184
2020
Q4
Sell
-11,973
Closed -$3.22M 261
2020
Q3
$3.22M Sell
11,973
-938
-7% -$252K 0.33% 56
2020
Q2
$3.4M Buy
12,911
+11,998
+1,314% +$3.2M 0.39% 48
2020
Q1
$207K Sell
913
-31
-3% -$8.45K 0.03% 210
2019
Q4
$285K Sell
944
-11
-1% -$3.03K 0.03% 259
2019
Q3
$229K Sell
955
-47
-5% -$12.9K 0.03% 265
2019
Q2
$283K Sell
1,002
-8
-0.8% -$2.19K 0.04% 270
2019
Q1
$290K Buy
1,010
+7
+0.7% +$2.02K 0.04% 265
2018
Q4
$263K Sell
1,003
-201
-17% -$55.3K 0.04% 242
2018
Q3
$330K Sell
1,204
-185
-13% -$48K 0.04% 240
2018
Q2
$331K Sell
1,389
-26,959
-95% -$6.24M 0.05% 241
2018
Q1
$6.23M Sell
28,348
-21,956
-44% -$5.16M 0.99% 34
2017
Q4
$11.3M Sell
50,304
-1,624
-3% -$346K 1.75% 14
2017
Q3
$9.86M Buy
51,928
+27,687
+114% +$5.27M 1.54% 27
2017
Q2
$4.56M Buy
24,241
+9,541
+65% +$1.71M 1.36% 25
2017
Q1
$2.43M Buy
14,700
+1,464
+11% +$233K 0.79% 40
2016
Q4
$1.9M Buy
+13,236
New +$1.77M 0.69% 45

Other funds holding ELV

Summit Global Investments's ELV Position: Q1 2026 in Review

Summit Global Investments reduced its Elevance Health (ELV) stake by 54% in Q1 2026, selling an estimated $1.71M and leaving 4,421 shares worth $1.29M. The position accounts for 0.08% of the portfolio, ranked #139.

Summit Global Investments first reported a position in ELV in Q4 2016 and has held it in 29 quarters since. The position peaked at $19.7M in Q3 2023. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Summit Global Investments held 4,421 shares of Elevance Health worth $1.29M as of Q1 2026.
  • Summit Global Investments sold 5,190 Elevance Health shares in Q1 2026, an estimated $1.71M.
  • Elevance Health made up 0.08% of Summit Global Investments's portfolio in Q1 2026, its #139 holding.
  • Summit Global Investments first reported a position in Elevance Health in Q4 2016 and has held it in 29 quarters since.
  • Summit Global Investments's Elevance Health position peaked at $19.7M in Q3 2023.
  • 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Summit Global Investments's 13F filing for Q1 2026, filed 7 May 2026.